Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

U.S. Precision Medicine (USPM) is developing DH20931, an AI-accelerated drug candidate targeting CerS2 for cancer therapeutics. With demonstrated 85% tumor reduction in preclinical trials, DH20931…

U.S. Precision Medicine (USPM) is developing DH20931, an AI-accelerated drug candidate targeting CerS2 for cancer therapeutics. With demonstrated 85% tumor reduction in preclinical trials, DH20931…
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
4,600+
New This Week